Ryzodeg is an injection medication containing two different types of insulin. But, it's discontinued and is no longer available in the U.S.
Ryzodeg is a combination insulin injection used for the treatment of type 1 and type 2 diabetes. It contains a long-acting insulin (insulin degludec) and a fast-acting insulin (insulin aspart). As a combination medication, it can lower the number of insulin injections needed every day.
No, Ryzodeg is not available in the U.S. because it was discontinued.
It's not clear why Ryzodeg was discontinued. But, it doesn't appear to be discontinued due to safety concerns.
